Too Old to Operate3h
Incidence of HIV Lower With Twice-Yearly Subcutaneous Lenacapavir
In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is ...
Labroots4h
Twice Yearly Injection 96% Reduces HIV Infection Risk by 96%
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
Medscape10h
HIV ‘Game-Changer’ Drug: Is Eastern Europe Missing Out?
A new, long-acting injectable to prevent HIV infection could be a “game-changer” in ending the AIDS epidemic, if all who ...
Japan Today12h
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
It’s been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% ...
Medical News Today19h
Lenacapavir injection lowers HIV risk by 96%
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
India Today20h
New injection reduces risk of HIV infection by 96%: All about it
A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...
Too Old to Operate21h
Lenacapavir Reduces HIV Incidence in High-Risk Populations
Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...
AllAfrica.com23h
Africa: Five Things You Should Know About the HIV Epidemic
Analysis - It is 40 years since Aids was first identified. Major strides have been made since the spread of the virus reached ...